These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 32671901

  • 21. Testing for BRAF (V600E) Mutation in Thyroid Nodules with Fine-Needle Aspiration (FNA) Read as Suspicious for Malignancy (Bethesda V, Thy4, TIR4): a Systematic Review and Meta-analysis.
    Trimboli P, Scappaticcio L, Treglia G, Guidobaldi L, Bongiovanni M, Giovanella L.
    Endocr Pathol; 2020 Mar; 31(1):57-66. PubMed ID: 31811566
    [Abstract] [Full Text] [Related]

  • 22. Value of BRAF V600E in High-Risk Thyroid Nodules with Benign Cytology Results.
    Chen X, Zhou Q, Wang F, Zhang F, Du H, Zhang Q, Wu W, Gong X.
    AJNR Am J Neuroradiol; 2018 Dec; 39(12):2360-2365. PubMed ID: 30498021
    [Abstract] [Full Text] [Related]

  • 23. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.
    Chung KW, Yang SK, Lee GK, Kim EY, Kwon S, Lee SH, Park DJ, Lee HS, Cho BY, Lee ES, Kim SW.
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):660-6. PubMed ID: 17054470
    [Abstract] [Full Text] [Related]

  • 24. Significance of FNAC, BRAF mutation, and intraoperative frozen section in surgical decision-making of thyroid nodules.
    Zhu Z, Su C, Chen G, Wan F, Jin M, Duan X, Wang Y, Wang G.
    Diagn Cytopathol; 2023 Jul; 51(7):441-448. PubMed ID: 37042168
    [Abstract] [Full Text] [Related]

  • 25. BRAFV600E mutation testing in fine needle aspirates of thyroid nodules: potential value of real-time PCR.
    Kwak JY, Han KH, Yoon JH, Kim EK, Moon HJ, Kim YL, Park SJ, Choi JR.
    Ann Clin Lab Sci; 2012 Jul; 42(3):258-65. PubMed ID: 22964613
    [Abstract] [Full Text] [Related]

  • 26. Detection of BRAF V600E in Fine-Needle Aspiration Samples of Thyroid Nodules by Droplet Digital PCR.
    Lu SY, Chen YC, Feng JL, Zhou QY, Chen J, Zhu CF, Guo MM, Zhang MM, Zhang QY, Lu M, Yang L, Wu J, Zhao SX, Song HD, Ye XP.
    Int J Endocrinol; 2022 Jul; 2022():6243696. PubMed ID: 35392249
    [Abstract] [Full Text] [Related]

  • 27. Contribution of the BRAF mutation analysis in calcified thyroid nodules.
    Yoo EY, Shin JH, Ko EY, Han BK.
    AJR Am J Roentgenol; 2012 Apr; 198(4):891-5. PubMed ID: 22451557
    [Abstract] [Full Text] [Related]

  • 28. What to do with thyroid nodules showing benign cytology and BRAF(V600E) mutation? A study based on clinical and radiologic features using a highly sensitive analytic method.
    Kim SY, Kim EK, Kwak JY, Moon HJ, Yoon JH.
    Surgery; 2015 Feb; 157(2):354-61. PubMed ID: 25616949
    [Abstract] [Full Text] [Related]

  • 29. A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates.
    Marchetti I, Lessi F, Mazzanti CM, Bertacca G, Elisei R, Coscio GD, Pinchera A, Bevilacqua G.
    Thyroid; 2009 Aug; 19(8):837-42. PubMed ID: 19534623
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of the Real-Q BRAF V600E Detection Assay in Fine-Needle Aspiration Samples of Thyroid Nodules.
    Park KS, Oh YL, Ki CS, Kim JW.
    J Mol Diagn; 2015 Jul; 17(4):431-7. PubMed ID: 25937618
    [Abstract] [Full Text] [Related]

  • 31. Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis.
    Marchetti I, Iervasi G, Mazzanti CM, Lessi F, Tomei S, Naccarato AG, Aretini P, Alberti B, Di Coscio G, Bevilacqua G.
    Thyroid; 2012 Mar; 22(3):292-8. PubMed ID: 22181337
    [Abstract] [Full Text] [Related]

  • 32. False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma.
    Paek SH, Kim BS, Kang KH, Kim HS.
    World J Surg Oncol; 2017 Nov 13; 15(1):202. PubMed ID: 29132392
    [Abstract] [Full Text] [Related]

  • 33. Analysis of BRAF(V600E) mutation and DNA methylation improves the diagnostics of thyroid fine needle aspiration biopsies.
    Zhang B, Liu S, Zhang Z, Wei J, Qu Y, Wu K, Yang Q, Hou P, Shi B.
    Diagn Pathol; 2014 Mar 03; 9():45. PubMed ID: 24588959
    [Abstract] [Full Text] [Related]

  • 34. Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology.
    Johnson SJ, Hardy SA, Roberts C, Bourn D, Mallick U, Perros P.
    Cytopathology; 2014 Jun 03; 25(3):146-54. PubMed ID: 24417615
    [Abstract] [Full Text] [Related]

  • 35. Cytomorphologic features in thyroid nodules read as "suspicious for malignancy" on cytology may predict thyroid cancers with the BRAF mutation.
    Kwon HJ, Kim EK, Kwak JY.
    Pathol Res Pract; 2015 Sep 03; 211(9):671-6. PubMed ID: 26187369
    [Abstract] [Full Text] [Related]

  • 36. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
    Rossi ED, Martini M, Bizzarro T, Capodimonti S, Cenci T, Lombardi CP, Pontecorvi A, Fadda G, Larocca LM.
    Cancer Cytopathol; 2015 Oct 03; 123(10):593-602. PubMed ID: 26230187
    [Abstract] [Full Text] [Related]

  • 37. Surgical results of thyroid nodules according to a management guideline based on the BRAF(V600E) mutation status.
    Kim SK, Hwang TS, Yoo YB, Han HS, Kim DL, Song KH, Lim SD, Kim WS, Paik NS.
    J Clin Endocrinol Metab; 2011 Mar 03; 96(3):658-64. PubMed ID: 21239517
    [Abstract] [Full Text] [Related]

  • 38. Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study.
    Rossi M, Buratto M, Bruni S, Filieri C, Tagliati F, Trasforini G, Rossi R, Beccati MD, Degli Uberti EC, Zatelli MC.
    J Clin Endocrinol Metab; 2012 Jul 03; 97(7):2354-61. PubMed ID: 22535974
    [Abstract] [Full Text] [Related]

  • 39. BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance.
    Adeniran AJ, Hui P, Chhieng DC, Prasad ML, Schofield K, Theoharis C.
    Acta Cytol; 2011 Jul 03; 55(6):570-5. PubMed ID: 22156468
    [Abstract] [Full Text] [Related]

  • 40. Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma".
    Jara SM, Bhatnagar R, Guan H, Gocke CD, Ali SZ, Tufano RP.
    Head Neck; 2015 Dec 03; 37(12):1788-93. PubMed ID: 24989827
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.